Imaging Technology

MAY 25, 2023

Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. We have many endocrine options now, and FES PET may identify patients who remain ER+ and thus potentially benefit from endocrine based therapy.”

Clinic 94

Clinic Healthcare Healthcare Imaging 94

Imaging Technology

JULY 3, 2024

At the center of the collaboration, the companies will integrate Nucleai’s predictive biomarker solutions into Proscia’s Concentriq software platform and make them available as part of Proscia’s precision medicine AI portfolio to better inform patient care. Along with today’s news, Nucleai joins the Proscia Ready partner alliance.

Pharmaceutical 59

Pharmaceutical Diagnostic Patient Care Clinic 59

Imaging Technology

APRIL 2, 2024

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. Together, we'll strive to continue our shared legacy of enhancing patient care.

Healthcare 105

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 105

Imaging Technology

JUNE 15, 2023

Additionally, clinicians believe that while AI can help to reduce care disparities (54 percent), the technology is also subject to built-in biases (44 percent).

Healthcare 98

Healthcare Healthcare Clinic Pharmaceutical 98

Imaging Technology

OCTOBER 2, 2024

2, Proscia launched Concentriq Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics. In a production setting, pharmaceutical companies can reduce AI development time from weeks to hours—allowing therapies to reach patients much sooner.

Pharmaceutical 52

Pharmaceutical Patient Care Diagnose Imaging 52

Imaging Technology

SEPTEMBER 7, 2023

It allows the two companies to join forces in the fight against cancer, as it allows them to make headway in their collaboration to transform cancer diagnosis and patient care. Paige Founder and Chief Scientist, Thomas Fuchs, Dr.Sc.

Imaging 52

Imaging Pharmaceutical Hospital Clinic 52

AuntMinnie

JUNE 14, 2024

Predicting outcomes, progression The ability to predict treatment outcomes and disease progression is crucial for optimizing patient care and guiding therapeutic decisions. Similarly, in diabetes, non-invasive imaging can assess pancreatic health and monitor for complications, revolutionizing patient care.

Imaging 130

Imaging Imaging Modalities Disease Medical Imaging 130

AuntMinnie

AUGUST 5, 2024

Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. That's what has happened to hundreds of people worldwide who have developed nephrogenic systemic fibrosis (NSF), an acquired disorder in renal patients that's been classified only since 2000. "Ask Giles, U.K.

Disease 290

Disease MRI Radiologist X-ray 290